Latest Kaiser Health News Stories
The topic, which polls show is top of mind among voters, kept returning throughout the fourth debate of Democratic presidential candidates.
Denver is considering adopting a new 911 alternative used in Eugene, Ore., that allows mental health and medical professionals, not police officers, to respond to some emergency calls, saving money and de-escalating situations with mentally ill people.
With federal authorities offering few details about what is causing the deadly outbreak of vaping-related lung illnesses, vaping advocates are crafting an alternative narrative reverberating through online communities.
The vaping hoodie. The vaping watch. The vaping phone case. Each ready to deliver a puff of nicotine (or marijuana) anywhere, anytime. The vaping market is crowded with sleek, camouflaged devices that have teachers and parents struggling to monitor illicit usage of a product that has surged in popularity among high schoolers.
Programs for health care professionals addicted to opioids generally bar a proven recovery method: the use of drugs like buprenorphine and methadone to relieve cravings.
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
An average of three people a day died of opioid overdose in Philadelphia in 2018. But efforts to combat the crisis with a supervised injection site could be stymied by “the crackhouse statute,” a portion of federal law meant to protect neighborhoods during the crack epidemic of the 1980s.
KHN’s Sarah Varney discussed opioid painkillers in India with NPR’s Rachel Martin on “Morning Edition” Thursday.
President Donald Trump keeps promising a new health plan, but so far it’s nowhere to be seen. Meanwhile, Democratic presidential candidate Sen. Bernie Sanders (I-Vt.) is proposing a plan to cancel billions of dollars in medical debt owed by patients. This week, Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Rovner also interviews KHN’s Rachel Bluth about the latest “Bill of the Month” feature. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
As schools begin a new year, more districts will test students as young as 11 for illicit drug use even as other drug prevention efforts are scaled back. More than 1 in 3 school districts nationwide give students drug tests.
Thomas Insel, who ran the National Institute of Mental Health for 13 years before casting his lot with Silicon Valley, is taking a temporary break from his senior position at a health care startup to advise Gov. Gavin Newsom on how to remake mental health care in the Golden State.
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
It can be difficult to get a prescription for buprenorphine, one of the gold standards for treating opioid use disorder. And not all pharmacies stock the drug.
Research out Wednesday indicates that guidelines are making strides in cutting back the number of pain pills doctors offer after specific types of surgeries.
Presidential candidate Joe Biden unveiled a health plan intended to provide a more moderate alternative to his competitors’ “Medicare for All” plans. It would build on the Affordable Care Act but would go much further. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss this, plus Planned Parenthood’s very bad week, the U.S. House vote to repeal the health law’s “Cadillac tax” on generous health plans, and the reduction in deaths from opioids.